The Association between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Sample Collection
2.2. Biochemical Assays
2.3. Diagnosis of Dyslipidemia
2.4. Statistical Analysis
3. Results
3.1. Association between Dyslipidemia with Anthropometric Measurements
3.2. Patterns of Food Intake in Studied Men and Women
3.2.1. Association between Food Intake and Dyslipidemia in Men
3.2.2. Association between Food Intake and Dyslipidemia in Women
3.3. Association between Lifestyle Characteristics and Dyslipidemia in Men and Women
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
References
- World Health Organization. Cardiovascular Diseases (CVDs). Available online: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed on 17 June 2020).
- Al-Nozha, M.; Arafah, M.; Al-Mazrou, Y.; Al-Maatouq, M.; Khan, N.; Khalil, M.; Al-Khadra, A.; Al-Marzouki, K.; Abdullah, M.; Al-Harthi, S. Coronary artery disease in Saudi Arabia. Saudi Med. J. 2004, 25, 1165–1171. [Google Scholar]
- World Health Organization; United Nations Development Programme. Prevention and Control of Noncommunicable Diseases in the Kingdom of Saudi Arabia: The Case for Investment. Available online: https://www.sa.undp.org/content/saudi_arabia/en/home/library/poverty/prevention-and-control-of-noncommunicable-diseases-in-the-kingdo.html (accessed on 17 June 2020).
- Ahmed, A.M.; Hersi, A.; Mashhoud, W.; Arafah, M.R.; Abreu, P.C.; Al Rowaily, M.A.; Al-Mallah, M. Cardiovascular risk factors burden in Saudi Arabia: The Africa Middle East cardiovascular epidemiological (ACE) study. J. Saudi Heart Assoc. 2017, 29, 235–243. [Google Scholar] [CrossRef] [PubMed]
- Tietge, U.J. Hyperlipidemia and cardiovascular disease: Inflammation, dyslipidemia, and atherosclerosis. Curr. Opin. Lipidol. 2014, 25, 94–95. [Google Scholar] [CrossRef] [PubMed]
- World Heart Federation. Cardiovascular Risk Factors. Available online: https://www.world-heart-federation.org/resources/risk-factors/ (accessed on 17 June 2020).
- Barter, P.; Gotto, A.M.; LaRosa, J.C.; Maroni, J.; Szarek, M.; Grundy, S.M.; Kastelein, J.J.P.; Bittner, V.; Fruchart, J.-C. HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events. N. Engl. J. Med. 2007, 357, 1301–1310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chang, W.-T.; Yin, W.-H.; Lin, F.-J.; Tseng, W.-K.; Wu, Y.-W.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. Non-High-Density-Lipoprotein Cholesterol is an Important Residual Risk Factor in the Secondary Prevention for Patients With Established Atherosclerotic Cardiovascular Diseases. Circulation 2016, 134, A16414. [Google Scholar]
- Al-Nozha, M.; Arafah, M.; Al-Maatouq, M.; Khalil, M.; Khan, N.; Al-Marzouki, K.; Al-Mazrou, Y.; Abdullah, M.; Al-Khadra, A.; Al-Harthi, S.; et al. Hyperlipidemia in Saudi Arabia. Saudi Med. J. 2008, 29, 282–287. [Google Scholar] [PubMed]
- Basulaiman, M.; El Bcheraoui, C.; Tuffaha, M.; Robinson, M.; Daoud, F.; Jaber, S.; Mikhitarian, S.; Wilson, S.; Memish, Z.A.; Al Saeedi, M.; et al. Hypercholesterolemia and its associated risk factors—Kingdom of Saudi Arabia, 2013. Ann. Epidemiol. 2014, 24, 801–808. [Google Scholar] [CrossRef] [PubMed]
- Alkaabba, A.; Al-Hamdan, N.; Tahir, A.; Abdalla, A.; Hussein, G.; Saeed, A.; Hamza, M.A. Prevalence and Correlates of Dyslipidemia among Adults in Saudi Arabia: Results from a National Survey. Open J. Endocr. Metab. Dis. 2012, 2, 89. [Google Scholar] [CrossRef] [Green Version]
- Al-Hassan, Y.; Fabella, E.; Estrella, E.; Aatif, M. Prevalence and Determinants of Dyslipidemia: Data from a Saudi University Clinic. Open Public Health J. 2018, 11, 416–424. [Google Scholar] [CrossRef]
- Opoku, S.; Gan, Y.; Fu, W.; Chen, D.; Addo-Yobo, E.; Trofimovitch, D.; Yue, W.; Yan, F.; Wang, Z.; Lu, Z. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: Findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health 2019, 19, 1500. [Google Scholar] [CrossRef]
- Itani, O.; Jike, M.; Watanabe, N.; Kaneita, Y. Short sleep duration and health outcomes: A systematic review, meta-analysis, and meta-regression. Sleep Med. 2017, 32, 246–256. [Google Scholar] [CrossRef] [PubMed]
- Darnton-Hill, I.; Nishida, C.; James, W. A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr. 2004, 7, 101–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ziegler, O.; Got, I.; Jan, P.; Drouin, P. Diet therapy of hypercholesterolemia. From theory to practice. In Proceedings of Annales de cardiologie et d’angeiologie. Ann. Cardiol. Angeiol. (Paris) 1989, 38, 249–253. [Google Scholar] [PubMed]
- Bahijri, S.; Al-Raddadi, R.; Ajabnoor, G.; Jambi, H.; Al Ahmadi, J.; Borai, A.; Barengo, N.C.; Tuomilehto, J. Dysglycemia risk score in Saudi Arabia: A tool to identify people at high future risk of developing type 2 diabetes. J. Diabetes Investig. 2020, 11, 844–855. [Google Scholar] [CrossRef]
- Lindström, J.; Tuomilehto, J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26, 725–731. [Google Scholar] [CrossRef] [Green Version]
- Saaristo, T.; Peltonen, M.; Keinänen-Kiukaanniemi, S.; Vanhala, M.; Saltevo, J.; Niskanen, L.; Oksa, H.; Korpi-Hyövälti, E.; Tuomilehto, J. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int. J. Circumpolar Health 2007, 66, 101–112. [Google Scholar] [CrossRef]
- Kaczorowski, J.; Robinson, C.; Nerenberg, K. Development of the CANRISK questionnaire to screen for prediabetes and undiagnosed type 2 diabetes. Can. J. Diabetes 2009, 33, 381–385. [Google Scholar] [CrossRef]
- Makrilakis, K.; Liatis, S.; Grammatikou, S.; Perrea, D.; Stathi, C.; Tsiligros, P.; Katsilambros, N. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 2011, 37, 144–151. [Google Scholar] [CrossRef]
- Franciosi, M.; De Berardis, G.; Rossi, M.C.; Sacco, M.; Belfiglio, M.; Pellegrini, F.; Tognoni, G.; Valentini, M.; Nicolucci, A. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 2005, 28, 1187–1194. [Google Scholar] [CrossRef] [Green Version]
- Al-Lawati, J.; Tuomilehto, J. Diabetes risk score in Oman: A tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res. Clin. Pract. 2007, 77, 438–444. [Google Scholar] [CrossRef]
- Karter, A.; D’Agostino, R., Jr.; Mayer-Davis, E.; Wagenknecht, L.; Hanley, A.; Hamman, R.; Bergman, R.; Saad, M.; Haffner, S. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes. Metab. 2005, 7, 230–238. [Google Scholar] [CrossRef] [PubMed]
- Zhu, S.; Wang, Z.; Heshka, S.; Heo, M.; Faith, M.; Heymsfield, S. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. Am. J. Clin. Nutr. 2002, 76, 743. [Google Scholar] [CrossRef] [PubMed]
- Friedewald, W.; Levy, R.; Fredrickson, D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499–502. [Google Scholar] [CrossRef] [PubMed]
- Alberti, K.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.-C.; James, W.P.T.; Loria, C.M.; Smith, S., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120, 1640–1645. [Google Scholar] [PubMed] [Green Version]
- National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (Ncep) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel IiI); National Cholesterol Education Program, National Heart, Lung, and Blood: Bethesda, MD, USA, 2002.
- Field, A. Discovering Statistics Using IBM SPSS Statistics; SAGE: London, UK, 2013. [Google Scholar]
- Erem, C.; Hacihasanoglu, A.; Deger, O.; Kocak, M.; Topbas, M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine 2008, 34, 36–51. [Google Scholar] [CrossRef] [PubMed]
- Polychronopoulos, E.; Panagiotakos, D.B.; Polystipioti, A. Diet, lifestyle factors and hypercholesterolemia in elderly men and women from Cyprus. Lipids Health Dis. 2005, 4, 17. [Google Scholar] [CrossRef] [Green Version]
- Al Amri, T.; Bahijri, S.; Al-Raddadi, R.; Ajabnoor, G.; Al Ahmadi, J.; Jambi, H.; Borai, A.; Tuomilehto, J. The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia. Diabetes Metab. Syndr. Obes. Targets Ther. 2019, 12, 2735–2743. [Google Scholar] [CrossRef] [Green Version]
- Sharifi, F.; Mousavinasab, S.; Soruri, R.; Saeini, M.; Dinmohammadi, M. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population. Metab. Syndr. Relat. Disord. 2008, 6, 187–195. [Google Scholar] [CrossRef]
- Jike, M.; Itani, O.; Watanabe, N.; Buysse, D.J.; Kaneita, Y. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Med. Rev. 2018, 39, 25–36. [Google Scholar] [CrossRef]
- Wang, D.; Chen, J.; Zhou, Y.; Ma, J.; Zhou, M.; Xiao, L.; He, M.; Zhang, X.; Guo, H.; Yuan, J.; et al. Association between sleep duration, sleep quality and hyperlipidemia in middle-aged and older Chinese: The Dongfeng–Tongji Cohort Study. Eur. J. Prev. Cardiol. 2019, 26, 1288–1297. [Google Scholar] [CrossRef]
- Bin, Y.S.; Marshall, N.S.; Glozier, N. Sleeping at the limits: The changing prevalence of short and long sleep durations in 10 countries. Am. J. Epidemiol. 2013, 177, 826–833. [Google Scholar] [CrossRef] [Green Version]
- Spiegel, K.; Leproult, R.; Van Cauter, E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354, 1435–1439. [Google Scholar] [CrossRef]
- Bahijri, S.; Borai, A.; Ajabnoor, G.; Khaliq, A.A.; AlQassas, I.; Al-Shehri, D.; Chrousos, G. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PLoS ONE 2013, 8, e60917. [Google Scholar] [CrossRef] [PubMed]
- Ward, A.M.V.; Fall, C.H.D.; Stein, C.E.; Kumaran, K.; Veena, S.R.; Wood, P.J.; Syddall, H.E.; Phillips, D.I.W. Cortisol and the metabolic syndrome in South Asians. Clin. Endocrinol. 2003, 58, 500–505. [Google Scholar] [CrossRef] [Green Version]
- Whitworth, J.A.; Williamson, P.M.; Mangos, G.; Kelly, J.J. Cardiovascular consequences of cortisol excess. Vasc. Health Risk Manag. 2005, 1, 291–299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Strandhagen, E.; Thelle, D.S. Filtered coffee raises serum cholesterol: Results from a controlled study. Eur. J. Clin. Nutr. 2003, 57, 1164–1168. [Google Scholar] [CrossRef] [PubMed]
- Cai, L.; Ma, D.; Zhang, Y.; Liu, Z.; Wang, P. The effect of coffee consumption on serum lipids: A meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 2012, 66, 872–877. [Google Scholar] [CrossRef] [PubMed]
- Urgert, R.; Katan, M.B. The cholesterol-raising factor from coffee beans. Annu. Rev. Nutr. 1997, 17, 305–324. [Google Scholar] [CrossRef] [Green Version]
- Nystad, T.; Melhus, M.; Brustad, M.; Lund, E. The effect of coffee consumption on serum total cholesterol in the Sami and Norwegian populations. Public Health Nutr. 2010, 13, 1818–1825. [Google Scholar] [CrossRef] [Green Version]
- Jacobson, T.A.; Maki, K.C.; Orringer, C.E.; Jones, P.H.; Kris-Etherton, P.; Sikand, G.; La Forge, R.; Daniels, S.R.; Wilson, D.P.; Morris, P.B.; et al. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J. Clin. Lipidol. 2015, 9, S1–S122.e121. [Google Scholar] [CrossRef] [Green Version]
- Namazi, N.; Larijani, B.; Surkan, P.J.; Azadbakht, L. The association of neck circumference with risk of metabolic syndrome and its components in adults: A systematic review and meta-analysis. Nutr. Metab. Cardiovasc. Dis. NMCD 2018, 28, 657–674. [Google Scholar] [CrossRef]
- Ferder, L.; Ferder, M.D.; Inserra, F. The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr. Hypertens. Rep. 2010, 12, 105–112. [Google Scholar] [CrossRef] [PubMed]
- Karupaiah, T.; Chuah, K.A.; Chinna, K.; Matsuoka, R.; Masuda, Y.; Sundram, K.; Sugano, M. Comparing effects of soybean oil- and palm olein-based mayonnaise consumption on the plasma lipid and lipoprotein profiles in human subjects: A double-blind randomized controlled trial with cross-over design. Lipids Health Dis. 2016, 15, 131. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shin, D.Y.; Jang, Y.K.; Lee, J.H.; Wee, J.H.; Chun, D.H. Relationship with Smoking and Dyslipidemia in Korean Adults. J. Korean Soc. Res. Nicotine Tob. 2017, 8, 73–79. [Google Scholar] [CrossRef] [Green Version]
- Mouhamed, D.H.; Ezzaher, A.; Neffati, F.; Gaha, L.; Douki, W.; Najjar, M. Association between cigarette smoking and dyslipidemia. Immuno-analyse Biol. Spécialisée 2013, 28, 195–200. [Google Scholar] [CrossRef]
- Tan, X.; Jiao, G.; Ren, Y.; Gao, X.; Ding, Y.; Wang, X.; Xu, H. Relationship between smoking and dyslipidemia in western Chinese elderly males. J. Clin. Lab. Anal. 2008, 22, 159–163. [Google Scholar] [CrossRef]
- Høstmark, A.T.; Tomten, S.E. Cola intake and serum lipids in the Oslo Health Study. Appl. Physiol. Nutr. Metab. 2009, 34, 901–906. [Google Scholar] [CrossRef]
- Dunnigan, M.; Fyfe, T.; McKiddie, M.; Crosbie, S. The effects of isocaloric exchange of dietary starch and sucrose on glucose tolerance, plasma insulin and serum lipids in man. Clin. Sci. 1970, 38, 1–9. [Google Scholar] [CrossRef]
- Crichton, G.E.; Alkerwi, A.a. Physical activity, sedentary behavior time and lipid levels in the Observation of Cardiovascular Risk Factors in Luxembourg study. Lipids Health Dis. 2015, 14, 87. [Google Scholar] [CrossRef] [Green Version]
- Leclerc, S.; Allard, C.; Talbot, J.; Gauvin, R.; Bouchard, C. High density lipoprotein cholesterol, habitual physical activity and physical fitness. Atherosclerosis 1985, 57, 43–51. [Google Scholar] [CrossRef]
- Wang, Y.; Xu, D. Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 2017, 16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kobayashi, Y.; Hirose, T.; Tada, Y.; Tsutsumi, A.; Kawakami, N. Relationship between Two Job Stress Models and Coronary Risk Factors among Japanese Part-Time Female Employees of a Retail Company. J. Occup. Health 2005, 47, 201–210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maierean, S.M.; Serban, M.-C.; Sahebkar, A.; Ursoniu, S.; Serban, A.; Penson, P.; Banach, M. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis. J. Clin. Lipidol. 2017, 11, 1393–1406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Men | Women | χ2 (p-Value) | |
---|---|---|---|
N (N%) | N (N%) | ||
Fruit (portion) | |||
No intake | 111 (14.0%) | 72 (11.8%) | 1.727 p = 0.422 |
1–4/week | 399 (50.4%) | 323 (52.8%) | |
5 or more/week | 281 (35.5%) | 217 (35.5%) | |
Fresh vegetable (portion) | |||
No intake | 115 (14.5%) | 53 (8.7%) | 15.259 p < 0.001 |
1–4/week | 310 (39.2%) | 225 (36.8%) | |
5 or more/week | 366 (46.3%) | 334 (54.6%) | |
Cooked vegetable (portion) | |||
No intake | 164 (20.7%) | 67 (10.9%) | 27.975 p < 0.001 |
1–4/week | 356 (45.0%) | 278 (45.4%) | |
5 or more/week | 271 (34.3%) | 267 (43.6%) | |
Whole grains (portion) | |||
No intake | 113 (14.3%) | 93 (15.2%) | 3.187 p = 0.203 |
1–4/week | 146 (18.5%) | 91 (14.9%) | |
5 or more/week | 532 (67.3%) | 428 (69.9%) | |
Red meat (portion) | |||
No intake | 58 (7.3%) | 139 (22.7%) | 77.64 p < 0.001 |
1–4/week | 453 (57.3%) | 335 (54.7%) | |
5 or more/week | 280 (35.4%) | 138 (22.5%) | |
Fresh juice (portion) | |||
No intake | 182 (23.0%) | 186 (30.4%) | 10.039 p = 0.007 |
1–4/week | 412 (52.1%) | 281 (45.9%) | |
5 or more/week | 197 (24.9%) | 145 (23.7%) | |
Non fresh juice (portion) | |||
No intake | 252 (31.9%) | 259 (42.3%) | 20.572 p < 0.001 |
1–4/week | 253 (32.0%) | 191 (31.2%) | |
5 or more/week | 286 (36.2%) | 162 (26.5%) | |
Soft drinks (portion) | |||
No intake | 247 (31.2%) | 298 (48.7%) | 56.848 p < 0.001 |
1–4/week | 233 (29.5%) | 175 (28.6%) | |
5 or more/week | 311 (39.3%) | 139 (22.7%) | |
Red tea (portion) | |||
No intake | 166 (21.0%) | 182 (29.7%) | 14.346 p = 0.001 |
1–4/week | 201 (25.4%) | 133 (21.7%) | |
5 or more/week | 424 (53.6%) | 297 (48.5%) | |
Green tea (portion) | |||
No intake | 464 (58.7%) | 323 (52.8%) | 7.39 p = 0.025 |
1–4/week | 168 (21.2%) | 130 (21.2%) | |
5 or more/week | 159 (20.1%) | 159 (26.0%) | |
Arabic coffee (portion) | |||
No intake | 347 (43.9%) | 232 (37.9%) | 10.33 p = 0.006 |
1–4/week | 214 (27.1%) | 153 (25.0%) | |
5 or more/week | 230 (29.1%) | 227 (37.1%) | |
Turkish coffee (portion) | |||
No intake | 565 (71.4%) | 440 (71.9%) | 0.112 p = 0.946 |
1–4/week | 124 (15.7%) | 92 (15.0%) | |
5 or more/week | 102 (12.9%) | 80 (13.1%) | |
American coffee (portion) | |||
No intake | 626 (79.1%) | 531 (86.8%) | 14.183 p = 0.001 |
1–4/week | 81 (10.2%) | 43 (7.0%) | |
5 or more/week | 84 (10.6%) | 38 (6.2%) | |
Cappuccino (portion) | |||
No intake | 536 (67.8%) | 368 (60.1%) | 9.881 p = 0.007 |
1–4/week | 157 (19.8%) | 139 (22.7%) | |
5 or more/week | 98 (12.4%) | 105 (17.2%) | |
Energy drinks (portion) | |||
No intake | 623 (78.8%) | 545 (89.1%) | 26.237 p < 0.001 |
1–4/week | 115 (14.5%) | 45 (7.4%) | |
5 or more/week | 53 (6.7%) | 22 (3.6%) | |
Hibiscus drinks (portion) | |||
No intake | 719 (90.9%) | 556 (90.8%) | 0.57 p = 0.752 |
1–4/week | 58 (7.3%) | 42 (6.9%) | |
5 or more/week | 14 (1.8%) | 14 (2.3%) | |
Cinnamon drink (portion) | |||
No intake | 707 (89.4%) | 478 (78.1%) | 37.241 p < 0.001 |
1–4/week | 52 (6.6%) | 100 (16.3%) | |
5 or more/week | 32 (4.0%) | 34 (5.6%) |
Variable | General Dyslipidemia | LDL-C | HDL-C | TC | TG | |||||
---|---|---|---|---|---|---|---|---|---|---|
No (n = 287) | Yes (n = 491) | Normal (n = 437) | High (n = 341) | Normal (n = 607) | Low (n = 171) | Normal (n = 501) | High (n = 277) | Normal (n = 560) | High (n = 218) | |
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Fruit (portion) | ||||||||||
No intake | 39 (35.8) | 70 (64.2) | 60 (55.0) | 49 (45.0) | 84 (77.1) | 25 (22.9) | 66 (60.6) | 43 (39.4) | 71 (65.1) | 38 (34.9) |
1–4/week | 154 (39.1) | 240 (60.9) | 217 (55.1) | 177 (44.9) | 328 (83.2) | 66 (16.8) | 256 (65.0) | 138 (35.0) | 290 (73.6) | 104 (26.4) |
5 or more/week | 94 (34.2) | 181 (65.8) | 160 (58.2) | 115 (41.8) | 195 (70.9) | 80 (29.1) | 179 (65.1) | 96 (34.9) | 199 (72.4) | 76 (27.6) |
X2 (p-value) | 1.74 (p = 0.419) | 0.7 (p = 0.705) | 14.448 (p = 0.001) | 0.818 (p = 0.664) | 3.066 (p = 0.216) | |||||
Fresh vegetable (portion) | ||||||||||
No intake | 43 (37.7) | 71 (62.3) | 68 (59.6) | 46 (40.4) | 91 (79.8) | 23 (20.2) | 72 (63.2) | 42 (36.8) | 78 (68.4) | 36 (31.6) |
1–4/week | 120 (39.3) | 185 (60.7) | 160 (52.5) | 145 (47.5) | 254 (83.3) | 51 (16.7) | 195 (63.9) | 110 (36.1) | 236 (77.4) | 69 (22.6) |
5 or more/week | 124 (34.5) | 235 (65.5) | 209 (58.2) | 150 (41.8) | 262 (73.0) | 97 (27.0) | 234 (65.2) | 125 (34.8) | 246 (68.5) | 113 (31.5) |
X2 (p-value) | 1.674 (p = 0.433) | 2.878 (p = 0.237) | 10.452 (p = 0.005) | 0.201 (p = 0.905) | 7.247 (p = 0.027) | |||||
Cooked vegetable (portion) | ||||||||||
No intake | 66 (41.3) | 94 (58.8) | 97 (60.6) | 63 (39.4) | 128 (80.0) | 32 (20.0) | 111 (69.4) | 49 (30.6) | 126 (78.8) | 34 (21.3) |
1–4/week | 128 (36.4) | 224 (63.4) | 187 (53.1) | 165 (46.9) | 291 (82.7) | 61 (17.3) | 212 (60.2) | 140 (39.8) | 245 (69.6) | 107 (30.4) |
5 or more/week | 93 (35.8) | 173 (65.0) | 153 (57.5) | 113 (42.5) | 188 (70.7) | 78 (29.3) | 178 (66.9) | 88 (33.1) | 189 (71.1) | 77 (28.9) |
X2 (p-value) | 1.773 (p = 0.412) | 2.812 (p = 0.245) | 13.17 (p = 0.001) | 5.136 (p = 0.077) | 4.736 (p = 0.077) | |||||
Whole grains (portion) | ||||||||||
No intake | 40 (36.4) | 70 (63.6) | 64 (58.2) | 46 (41.8) | 81 (73.6) | 29 (26.4) | 69 (62.7) | 41 (37.3) | 79 (71.8) | 31 (28.2) |
1–4/week | 54 (37.5) | 90 (62.5) | 77 (53.5) | 67 (46.5) | 118 (81.9) | 26 (18.1) | 8(61.1) | 56 (38.9) | 105 (72.9) | 39 (27.1) |
5 or more/week | 193 (36.8) | 331 (63.2) | 296 (56.5) | 228 (43.5) | 408 (77.9) | 116 (22.1) | 344 (65.6) | 180 (34.4) | 376 (71.8) | 148 (28.2) |
X2 (p-value) | 0.037 (p = 0.982) | 0.628 (p = 0.73) | 2.533 (p = 0.282) | 1.17 (p = 0.557) | 0.77 (p = 0.962) | |||||
Red meat (portion) | ||||||||||
No intake | 19 (33.3) | 38 (66.7) | 33 (57.9) | 24 (42.1) | 41 (71.9) | 16 (28.1) | 35 (61.4) | 22 (38.6) | 43 (75.4) | 14 (24.6) |
1–4/week | 167 (37.5) | 287 (62.5) | 260 (58.4) | 185 (41.6) | 347 (78.0) | 98 (22.0) | 290 (65.2) | 155 (34.8) | 317 (71.2) | 128 (28.8) |
5 or more/week | 101 (36.6) | 175 (63.4) | 144 (52.2) | 132 (47.8) | 219 (79.3) | 57 (20.7) | 176 (63.8) | 100 (36.2) | 200 (72.5) | 76 (27.5) |
X2 (p-value) | 0.398 (p = 0.82) | 2.78 (p = 0.249) | 1.517 (p = 0.468) | 0.386 (p = 0.825) | 0.492 (p = 0.782) | |||||
Fresh juice (portion) | ||||||||||
No intake | 72 (40.2) | 107 (59.8) | 112 (62.6) | 67 (37.4) | 133 (74.3) | 46 (25.7) | 124 (69.3) | 55 (30.7) | 128 (71.5) | 51 (28.5) |
1–4/week | 141 (34.8) | 264 (65.2) | 213 (52.6) | 192 (47.4) | 319 (78.8) | 86 (21.2) | 249 (61.5) | 156 (38.5) | 294 (72.6) | 111 (27.4) |
5 or more/week | 74 (38.1) | 120 (61.9) | 112 (57.7) | 82 (42.3) | 155 (79.9) | 39 (20.1) | 128 (66.0) | 66 (34.0) | 138 (71.1) | 56 (28.9) |
X2 (p-value) | 1.735 (p = 0.42) | 5.275 (p = 0.072) | 1.973 (p = 0.373) | 3.57 (p = 0.168) | 0.164 (p = 0.921) | |||||
Non fresh juice (portion) | ||||||||||
No intake | 87 (34.9) | 162 (65.1) | 141 (56.6) | 108 (43.4) | 186 (74.7) | 63 (25.3) | 155 (62.2) | 94 (37.8) | 179 (71.9 | 70 (28.1) |
1–4/week | 97 (38.8) | 153 (61.2) | 136 (54.4) | 114 (45.6) | 200 (80.0) | 50 (20.0) | 158 (63.2) | 92 (36.8) | 183 (73.2) | 67 (26.8) |
5 or more/week | 103 (36.9) | 176 (63.1) | 160 (57.3) | 119 (42.7) | 221 (79.2) | 58 (20.8) | 188 (67.4) | 91 (32.6) | 198 (71.0) | 81 (29.0) |
X2 (p-value) | 0.779 (p = 0.671) | 0.496 (p = 0.78) | 2.404 (p = 0.301) | 1.743 (p = 0.418) | 0.327 (p = 0.849) | |||||
Carbonated drinks (portion) | ||||||||||
No intake | 92 (38.2) | 149 (61.8) | 145 (60.2) | 96 (39.8) | 184 (76.3) | 57 (23.7) | 152 (63.1) | 89 (36.9) | 173 (71.8) | 68 (28.2) |
1–4/week | 88 (37.9) | 144 (62.1) | 126 (54.3) | 106 (45.7) | 187 (80.6) | 45 (19.4) | 155 (66.8) | 77 (33.2) | 171 (73.7) | 61 (26.3) |
5 or more/week | 107 (35.1) | 198 (64.9) | 166 (54.4) | 139 (45.6) | 236 (77.4) | 69 (22.6) | 194 (63.6) | 111 (36.4) | 216 (70.8) | 89 (29.2) |
X2 (p-value) | 0.707 (p = 0.702) | 2.266 (p = 0.322) | 1.369 (p = 0.504) | 0.857 (p = 0.615) | 0.551 (p = 0.759) | |||||
Red tea (portion) | ||||||||||
No intake | 61 (37.2) | 103 (62.8) | 98 (59.8) | 66 (40.2) | 130 (79.3) | 34 (20.7) | 112 (68.3) | 52 (31.7) | 124 (75.6) | 40 (24.4) |
1–4/week | 82 (41.6) | 115 (58.4) | 110 (55.8) | 87 (44.2) | 168 (85.3) | 29 (14.7) | 131 (66.5) | 66 (33.5) | 149 (75.6) | 48 (24.4) |
5 or more/week | 144 (34.5) | 273 (65.5) | 229 (54.9) | 188 (45.1) | 309 (74.1) | 108 (25.9) | 258 (61.9) | 159 (38.1) | 287 (68.8) | 130 (31.2) |
X2 (p-value) | 2.899 (p = 0.235) | 1.132 (p = 0568) | 9.938 (p = 0.007) | 2.626 (p = 0.269) | 4.434 (p = 0.109) | |||||
Green tea (portion) | ||||||||||
No intake | 174 (38.2) | 281 (61.8) | 263 (57.8) | 192 (42.2) | 354 (77.8) | 101 (22.2) | 304 (66.8) | 151 (33.2) | 329 (72.3) | 126 (27.7) |
1–4/week | 62 (37.6) | 103 (62.4) | 87 (52.7) | 78 (47.3) | 135 (81.8) | 30 (18.2) | 98 (59.4) | 67 (40.6) | 123 (74.5) | 42 (25.5) |
5 or more/week | 51 (32.3) | 107 (67.7) | 87 (55.1) | 71 (44.9) | 118 (74.7) | 40 (25.3) | 99 (62.7) | 59 (37.3) | 108 (68.4) | 50 (31.6) |
X2 (p-value) | 1.834 (p = 0.4) | 1.365 (p = 0.505) | 2.426 (p = 0.297) | 3.168 (p = 0.205) | 1.592 (p = 0.451) | |||||
Arabic coffee (portion) | ||||||||||
No intake | 124 (36.3) | 218 (63.7) | 197 (57.6) | 145 (42.4) | 261 (76.3) | 81 (23.7) | 218 (63.7) | 124 (36.3) | 236 (69.0) | 106 (31.0) |
1–4/week | 84 (40.0) | 126 (60.0) | 112 (53.3) | 98 (46.7) | 176 (83.8) | 34 (16.2) | 139 (66.2) | 71 (33.8) | 163 (77.6) | 47 (22.4) |
5 or more/week | 79 (35.0) | 147 (65.0) | 128 (56.6) | 98 (43.4) | 170 (75.2) | 56 (24.8) | 144 (63.7) | 82 (36.3) | 161 (71.2) | 65 (28.8) |
X2 (p-value) | 1.294 (p = 0.524) | 0.991 (p = 0.609) | 5.716 (p = 0.057) | 0.404 (p = 0.817) | 4.872 (p = 0.087) | |||||
Turkish coffee (portion) | ||||||||||
No intake | 212 (38.0) | 346 (62.0) | 317 (56.8) | 241 (43.2) | 434 (77.8) | 124 (22.2) | 361 (64.7) | 197 (35.3) | 401 (71.9) | 157 (28.1) |
1–4/week | 54 (44.6) | 67 (55.4) | 72 (59.5) | 49 (40.5) | 103 (85.1) | 18 (14.9) | 87 (71.9) | 34 (28.1) | 94 (77.7) | 27 (22.3) |
5 or more/week | 21 (21.2) | 78 (78.8) | 48 (48.5) | 51 (51.5) | 70 (70.7) | 29 (29.3) | 53 (53.5) | 46 (46.5) | 65 (65.7) | 34 (34.3) |
X2 (p-value) | 13.856(p ≤0.001) | 3.014 (p = 0.222) | 6.667 (p = 0.036) | 8.087 (p = 0.018) | 3.92 (p = 0.141) | |||||
American coffee (portion) | ||||||||||
No intake | 215 (34.8) | 402 (65.2) | 341 (55.3) | 276 (44.7) | 472 (76.5) | 145 (23.5) | 393 (63.7) | 224 (36.3) | 435 (70.5) | 182 (29.5) |
1–4/week | 40 (50.0) | 40 (50.0) | 53 (66.3) | 27 (33.8) | 69 (86.3) | 11 (13.8) | 63 (78.8) | 17 (21.3) | 64 (80.0) | 16 (20.0) |
5 or more/week | 32 (39.5) | 49 (60.5) | 43 (53.1) | 38 (46.9) | 66 (81.5) | 15 (18.5) | 45 (55.6) | 36 (44.4) | 61 (75.3) | 20 (24.7) |
X2 (p-value) | 7.251(p = 0.027) | 3.819 (p = 0.148) | 4.558 (p = 0.102) | 10.082 (p = 0.006) | 3.664 (p = 0.16) | |||||
Cappuccino (portion) | ||||||||||
No intake | 195 (36.9) | 333 (63.1) | 298 (56.4) | 230 (43.6) | 404 (76.5) | 124 (23.5) | 342 (64.8) | 186 (35.2) | 380 (72.0) | 148 (28.0) |
1–4/week | 64 (41.6) | 90 (58.4) | 88 (57.1) | 66 (42.9) | 130 (84.4) | 24 (15.6) | 104 (67.5) | 50 (32.5) | 114 (74.0) | 40 (26.0) |
5 or more/week | 28 (29.2) | 68 (70.8) | 51 (53.1) | 45 (46.9) | 73 (76.0) | 23 (24.0) | 55 (57.3) | 41 (42.7) | 66 (68.8) | 30 (31.3) |
X2 (p-value) | 3.902 (p = 0.142) | 0.436 (p = 0.804) | 4.59 (p = 0.101) | 2.807 (p = 0.246) | 0.816 (p = 0.665) | |||||
Energy drinks (portion) | ||||||||||
No intake | 219 (35.7) | 395 (64.3) | 338 (55.0) | 276 (45.0) | 468 (76.2) | 146 (23.8) | 389 (63.4) | 225 (36.6) | 432 (70.4) | 182 (29.6) |
1–4/week | 45 (39.8) | 68 (60.2) | 65 (57.5) | 48 (42.5) | 96 (85.0) | 17 (15.0) | 74 (65.5) | 39 (34.5) | 86 (76.1) | 27 (23.9) |
5 or more/week | 23 (45.1) | 28 (54.9) | 34 (66.7) | 17 (33.3) | 43 (84.3) | 8 (15.7) | 38 (74.5) | 13 (25.5) | 42 (82.4) | 9 (17.6) |
X2 (p-value) | 2.287 (p = 0.319) | 2.68 (p = 0.262) | 5.506 (p = 0.064) | 2.624 (p = 0.269) | 4.475 (p = 0.107) | |||||
Hibiscus drinks (portion) | ||||||||||
No intake | 271 (38.4) | 435 (61.6) | 406 (57.5) | 300 (42.5) | 557 (78.9) | 149 (21.1) | 460 (65.2) | 246 (34.8) | 516 (73.1) | 190 (26.9) |
1–4/week | 12 (20.7) | 46 (79.3) | 24 (41.4) | 34 (58.6) | 40 (69.0) | 18 (31.0) | 34 (58.6) | 24 (41.4) | 36 (62.1) | 22 (37.9) |
5 or more/week | 4 (28.6) | 10 (71.4) | 7 (50.0) | 7 (50.0) | 10 (71.4) | 4 (28.6) | 7 (50.0) | 7 (50.0) | 8 (57.1) | 6 (42.9) |
X2 (p-value) | 7.633(p = 0.022) | 5.883 (p = 0.053) | 3.443 (p = 0.179) | 2.287 (p = 0.319) | 4.782 (p = 0.092) | |||||
Cinnamon drink (portion) | ||||||||||
No intake | 268 (38.6) | 426 (61.4) | 398 (57.3) | 296 (42.7) | 549 (79.1) | 145 (20.9) | 457 (65.9) | 237 (34.1) | 511 (73.6) | 183 (26.4) |
1–4/week | 11 (21.2) | 41 (78.8) | 22 (42.3) | 30 (57.7) | 36 (69.2) | 16 (30.8) | 24 (46.2) | 28 (53.8) | 29 (55.8) | 23 (44.2) |
5 or more/week | 8 (25.0) | 24 (75.0) | 17 (53.1) | 15 (46.9) | 22 (68.8) | 10 (31.3) | 20 (62.5) | 12 (37.5) | 20 (62.5) | 12 (37.5) |
X2 (p-value) | 8.363 (p = 0.015) | 4.571 (p = 0.102) | 4.424 (p = 0.109) | 8.238 (p = 0.016) | 9.139 (p = 0.01) |
Covariate | Unadjusted | Adjusted for Age, BMI and WC |
---|---|---|
OR (95% CI) P | OR (95% CI) P | |
Turkish coffee intake | ||
p for trend | p < 0.001 | p = 0.001 |
No intake (reference) | ||
1–4 /week | 0.955 (0.604, 1.512) p = 0.846 | 0.929 (0.573, 1.507) p = 0.766 |
5 or more /week | 2.783 (1.566, 4.944) p < 0.001 | 2.737 (1.532, 4.889) p = 0.001 |
American coffee intake | ||
p for trend | p = 0.005 | p = 0.025 |
No intake (reference) | ||
1–4 /week | 0.469 (0.273, 0.805) p = 0.006 | 0.577 (0.326, 1.021) p = 0.059 |
5 or more /week | 0.544 (0.318, 0.933) p = 0.027 | 0.525 (0.298, 0.923) p = 0.025 |
Carbonated drinks intake | ||
p for trend | p > 0.15 | p = 0.093 |
No intake (reference) | ||
1–4 /week | 1.226 (0.815, 1.842) p = 0.326 | |
5 or more /week | 1.533 (1.041, 2.257) p = 0.03 | |
Sleep duration | ||
p for trend | p = 0.011 | p = 0.012 |
6–8 h (reference) | ||
<6 h | 1.566 (1.155, 2.123) p = 0.004 | 1.573 (1.137, 2.175) p = 0.006 |
>8 h | 1.545 (0.795, 3.003) p = 0.2 | 1.844 (0.88, 3.864) p = 0.105 |
Smoking | ||
p for trend | p > 0.15 | p = 0.073 |
Non-smokers (reference) | ||
Smokers | 1.41 (1.001, 1.986) p = 0.043 | |
Previous smokers | 0.755 (0.381, 1.497) p = 0.422 |
Variable | General Dyslipidemia | LDL-C | HDL-C | TC | TG | |||||
---|---|---|---|---|---|---|---|---|---|---|
No (n = 240) | Yes (n = 367) | Normal (n = 381) | High (n = 226) | Normal (n = 440) | Low (n = 167) | Normal (n = 404) | High (n = 203) | Normal (n = 524) | High (n = 82) | |
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Fruit (portion) | ||||||||||
No intake | 33 (47.1) | 37 (52.9) | 47 (67.1) | 23 (32.9) | 56 (80.0) | 14 (20.0) | 53 (75.7) | 17 (24.3) | 61 (87.1) | 9 (12.9) |
1–4/week | 123 (38.2) | 199 (61.8) | 209 (64.9) | 113 (35.1) | 219 (68.0) | 103 (32.0) | 221 (68.6) | 101 (31.4) | 284 (88.2) | 38 (11.8) |
5 or more/week | 84 (39.1) | 131 (60.9) | 125 (58.1) | 90 (41.9) | 165 (76.7) | 50 (23.3) | 130 (60.5) | 85 (39.5) | 179 (83.3) | 36 (16.7) |
X2 (p-value) | 1.955 (p = 0.372) | 3.174 (p = 0.204) | 7.168 (p = 0.028) | 6.846 (p = 0.033) | 2.713 (p = 0.258) | |||||
Fresh vegetable (portion) | ||||||||||
No intake | 33 (62.3) | 20 (37.7) | 42 (79.2) | 11 (20.8) | 44 (83.0) | 9 (17.0) | 45 (84.9) | 8 (15.1) | 50 (94.3) | 3 (5.7) |
1–4/week | 79 (35.3) | 145 (64.7) | 137 (61.2) | 87 (38.8) | 152 (67.9) | 72 (32.1) | 150 (67.0) | 74 (33.0) | 194 (86.6) | 30 (13.4) |
5 or more/week | 128 (28.8) | 202 (61.2) | 202 (61.2) | 128 (38.8) | 244 (73.9) | 86 (26.1) | 209 (63.3) | 121 (36.7) | 280 (84.8) | 50 (15.2) |
X2 (p-value) | 13.237 (p <0.001) | 6.747 (p = 0.034) | 5.704 (p = 0.058) | 9.574 (p = 0.008) | 3.509 (p = 0.173) | |||||
Cooked vegetable (portion) | ||||||||||
No intake | 32 (48.5) | 34 (51.5) | 42 (63.6) | 24 (36.4) | 53 (80.3) | 13 (19.7) | 51 (77.3) | 15 (22.7) | 58 (87.9) | 8 (12.1) |
1–4/week | 100 (36.1) | 177 (63.9) | 172 (62.1) | 105 (37.9) | 195 (70.4) | 82 (29.6) | 176 (63.5) | 101 (36.5) | 237 (85.6) | 40 (14.4) |
5 or more/week | 108 (40.9) | 156 (59.1) | 167 (63.3) | 97 (36.7) | 192 (72.7) | 72 (27.3) | 177 (67.0) | 87 (33.0) | 229 (86.7) | 35 (13.3) |
X2 (p-value) | 3.786 (p = 0.151) | 0.102 (p = 0.95) | 2.636 (p = 0.268) | 4.567 (p = 0.102) | 0.311 (p = 0.856) | |||||
Whole grains (portion) | ||||||||||
No intake | 40 (44.0) | 51 (56.0) | 61 (67.0) | 30 (33.0) | 64 (70.3) | 27 (29.7) | 66 (72.5) | 25 (27.5) | 81 (89.0) | 10 (11.0) |
1–4/week | 34 (37.4) | 57 (62.6) | 54 (59.3) | 37 (40.7) | 65 (71.4) | 26 (28.6) | 57 (62.6) | 34 (37.4) | 76 (83.5) | 15 (16.5) |
5 or more/week | 166 (39.1) | 259 (60.9) | 266 (62.6) | 159 (37.4) | 311 (73.2) | 114 (26.8) | 281 (66.1) | 144 (33.9) | 367 (86.4) | 58 (13.6) |
X2 (p-value) | 0.964 (p = 0.618) | 1.172 (p = 0.557) | 0.365 (p = 0.833) | 2.122 (p = 0.346) | 1.165 (p = 0.559) | |||||
Red meat (portion) | ||||||||||
No intake | 65 (46.8) | 74 (53.2) | 92 (66.2) | 47 (33.8) | 105 (75.5) | 34 (24.5) | 95 (68.3) | 44 (31.9) | 122 (87.8) | 17 (12.2) |
1–4/week | 113 (33.7) | 222 (66.3) | 204 (60.9) | 131 (39.1) | 231 (69.0) | 104 (31.0) | 217 (64.8) | 118 (35.2) | 287 (85.7) | 48 (14.3) |
5 or more/week | 62 (46.6) | 71 (53.4) | 85 (63.9) | 48 (36.1) | 104 (78.2) | 29 (21.8) | 92 (69.2) | 41 (30.8) | 115 (86.5) | 18 (13.5) |
X2 (p-value) | 10.547 (p = 0.005) | 1.272 (p = 0.529) | 4.918 (p = 0.086) | 1.086 (p = 0.581) | 0.369 (p = 0.831) | |||||
Fresh juice (portion) | ||||||||||
No intake | 78 (42.2) | 107 (57.8) | 118 (63.8) | 67 (36.2) | 134 (72.4) | 51 (27.6) | 127 (68.6) | 58 (31.4) | 167 (90.3) | 18 (9.7) |
1–4/week | 103 (36.9) | 176 (63.1) | 174 (62.4) | 105 (37.6) | 198 (71.0) | 81 (29.0) | 181 (64.9) | 98 (35.1) | 236 (84.6) | 43 (15.4) |
5 or more/week | 59 (41.3) | 84 (58.7) | 89 (62.2) | 54 (37.8) | 108 (75.5) | 35 (24.5) | 96 (67.1) | 47 (32.9) | 121 (84.6) | 22 (15.4) |
X2 (p-value) | 1.511 (p = 0.47) | 0.118 (p = 0.943) | 0.985 (p = 0.611) | 0.74 (p = 0.691) | 3.507 (p = 0.173) | |||||
Non fresh juice (portion) | ||||||||||
No intake | 93 (36.0) | 165 (64.0) | 158 (61.2) | 100 (38.8) | 183 (70.9) | 75 (29.1) | 160 (62.0) | 98 (38.0) | 220 (85.3) | 38 (14.7) |
1–4/week | 74 (38.9) | 116 (61.1) | 123 (64.7) | 67 (35.3) | 136 (71.6) | 54 (28.4) | 134 (70.5) | 56 (29.5) | 164 (86.3) | 26 (13.7) |
5 or more/week | 73 (45.9) | 86 (54.1) | 100 (62.9) | 59 (37.1) | 121 (76.1) | 38 (23.9) | 110 (69.2) | 49 (30.8) | 140 (88.1) | 19 (11.9) |
X2 (p-value) | 4.046 (p = 0.132) | 0.574 (p = 0.751) | 1.433 (p = 0.488) | 4.228 (p = 0.121) | 0.644 (p = 0.725) | |||||
Carbonated drinks (portion) | ||||||||||
No intake | 113 (38.2) | 183 (61.8) | 182 (61.5) | 114 (38.5) | 207 (69.9) | 89 (30.1) | 193 (65.2) | 103 (34.8) | 248 (83.8) | 48 (16.2) |
1–4/week | 68 (39.1) | 106 (60.9) | 108 (62.1) | 66 (37.9) | 130 (74.7) | 44 (25.3) | 115 (66.1) | 59 (33.9) | 156 (89.7) | 18 (10.3) |
5 or more/week | 59 (43.1) | 78 (56.9) | 91 (66.4) | 46 (33.6) | 103 (75.2) | 34 (24.8) | 96 (70.1) | 41 (29.9) | 120 (87.6) | 17 (12.4) |
X2 (p-value) | 0.958 (p = 0.619) | 1.028 (p = 0.598) | 1.9 (p = 0.387) | 1.022 (p = 0.6) | 3.44 (p = 0.179) | |||||
Red tea (portion) | ||||||||||
No intake | 79 (43.4) | 103 (56.6) | 125 (68.7) | 57 (31.3) | 129 (70.9) | 53 (29.1) | 136 (74.7) | 46 (25.3) | 161 (88.5) | 21 (11.5) |
1–4/week | 42 (32.1) | 89 (67.9) | 75 (57.3) | 56 (42.7) | 91 (69.5) | 40 (30.5) | 77 (58.8) | 54 (41.2) | 110 (84.0) | 21 (16.0) |
5 or more/week | 119 (40.5) | 175 (59.5) | 181 (61.6) | 113 (38.4) | 220 (74.8) | 74 (25.2) | 191 (65.0) | 103 (35.0) | 253 (86.1) | 41 (13.9) |
X2 (p-value) | 4.311 (p = 0.116) | 4.611 (p = 0.1) | 1.645 (p = 0.439) | 9.351 (p = 0.009) | 1.338 (p = 0.512) | |||||
Green tea (portion) | ||||||||||
No intake | 134 (41.9) | 186 (58.1) | 215 (67.2) | 105 (32.8) | 227 (70.9) | 93 (29.1) | 226 (70.6) | 94 (29.4) | 281 (87.8) | 39 (12.2) |
1–4/week | 50 (38.5) | 80 (61.5) | 75 (57.7) | 55 (42.3) | 94 (72.3) | 36 (27.7) | 85 (65.4) | 45 (34.6) | 108 (83.1) | 22 (16.9) |
5 or more/week | 56 (35.7) | 101 (64.3) | 91 (58.0) | 66 (42.0) | 119 (75.8) | 38 (24.2) | 93 (59.2) | 64 (40.8) | 135 (86.0) | 22 (14.0) |
X2 (p-value) | 1.777 (p = 0.411) | 5.659 (p = 0.059) | 1.249 (p = 0.535) | 6.24 (p = 0.044) | 1.777 (p = 0.411) | |||||
Arabic coffee (portion) | ||||||||||
No intake | 93 (40.4) | 137 (59.6) | 148 (64.3) | 82 (35.7) | 161 (70.0) | 69 (30.0) | 159 (69.1) | 71 (30.9) | 199 (86.5) | 31 (13.5) |
1–4/week | 57 (37.3) | 96 (62.7) | 98 (64.1) | 55 (35.9) | 104 (68.0) | 49 (32.0) | 104 (68.0) | 49 (32.0) | 130 (85.0) | 23 (15.0) |
5 or more/week | 90 (40.2) | 134 (59.8) | 135 (60.3) | 89 (39.7) | 175 (78.1) | 49 (21.9) | 141 (62.9) | 83 (37.1) | 195 (87.1) | 29 (12.9) |
X2 (p-value) | 0.449 (p = 0.799) | 0.953 (p = 0.621) | 5.846 (p = 0.054) | 2.134 (p = 0.344) | 0.347 (p = 0.841) | |||||
Turkish coffee (portion) | ||||||||||
No intake | 170 (39.1) | 265 (60.9) | 280 (64.4) | 155 (35.6) | 310 (71.3) | 125 (28.7) | 284 (65.3) | 151 (34.7) | 378 (86.9) | 57 (13.1) |
1–4/week | 31 (33.7) | 61 (66.3) | 52 (56.5) | 40 (43.5) | 65 (70.7) | 27 (29.3) | 64 (69.6) | 28 (30.4) | 77 (83.7) | 15 (16.3) |
5 or more/week | 39 (48.8) | 41 (51.2) | 49 (61.3) | 31 (38.8) | 65 (81.3) | 15 (18.8) | 56 (70.0) | 24 (30.0) | 69 (86.3) | 11 (13.8) |
X2 (p-value) | 4.192 (p = 0.123) | 2.091 (p = 0.351) | 3.562 (p = 0.168) | 1.115 (p = 0.573) | 0.66 (p = 0.719) | |||||
American coffee (portion) | ||||||||||
No intake | 212 (40.2) | 315 (59.8) | 332 (63.0) | 195 (37.0) | 382 (72.5) | 145 (27.5) | 353 (67.0) | 174 (33.0) | 460 (87.3) | 67 (12.7) |
1–4/week | 12 (27.9) | 31 (72.1) | 27 (62.8) | 16 (37.2) | 27 (62.8) | 16 (37.2) | 30 (69.8) | 13 (30.2) | 34 (79.1) | 9 (20.9) |
5 or more/week | 16 (43.2) | 21 (56.8) | 22 (59.5) | 15 (40.5) | 31 (83.8) | 6 (16.2) | 21 (56.8) | 16 (43.2) | 30 (81.1) | 7 (18.9) |
X2 (p-value) | 2.751 (p = 0.253) | 0.185 (p = 0.912) | 4.395 (p = 0.111) | 1.839 (p = 0.300) | 3.192 (p = 0.203) | |||||
Cappuccino (portion) | ||||||||||
No intake | 140 (38.6) | 223 (61.4) | 216 (59.5) | 147 (40.5) | 255 (70.2) | 108 (29.8) | 238 (65.6) | 125 (34.4) | 306 (84.3) | 57 (15.7) |
1–4/week | 60 (43.2) | 79 (56.8) | 99 (71.2) | 40 (28.8) | 104 (74.8) | 35 (25.2) | 98 (70.5) | 41 (29.5) | 123 (88.5) | 16 (11.5) |
5 or more/week | 40(38.1) | 65 (61.9) | 66 (62.9) | 39 (37.1) | 81 (77.1) | 24 (22.9) | 68 (64.8) | 37 (35.2) | 95 (90.5) | 10 (9.5) |
X2 (p-value) | 1 (p = 0.607) | 5.907 (p = 0.052) | 2.433 (p = 0.296) | 1.285 (p = 0.526) | 3.349 (p = 0.187) | |||||
Energy drinks (portion) | ||||||||||
No intake | 212 (39.3) | 328 (60.7) | 334 (61.9) | 206 (38.1) | 388 (71.9) | 152 (28.1) | 356 (65.9) | 184 (34.1) | 464 (85.9) | 76 (24.1) |
1–4/week | 15 (33.3) | 30 (66.7) | 31 (68.9) | 14 (31.1) | 32 (71.1) | 13 (28.9) | 30 (66.7) | 15 (33.3) | 40 (88.9) | 5 (11.1) |
5 or more/week | 13 (59.1) | 9 (40.9) | 16 (72.7) | 6 (27.3) | 20 (90.9) | 2 (9.1) | 18 (81.8) | 4 (18.2) | 20 (90.0) | 2 (9.1) |
X2 (p-value) | 2.261 (p = 0.119) | 1.849 (p = 0.397) | 3.896 (p = 0.143) | 2.399 (p = 0.301) | 0.715 (p = 0.699) | |||||
Hibiscus drinks (portion) | ||||||||||
No intake | 220 (39.9) | 331 (60.1) | 352 (63.9) | 199 (36.1) | 396 (71.9) | 155 (28.1) | 374 (67.9) | 177 (32.1) | 474 (86.0) | 77 (14.0) |
1–4/week | 15 (35.7) | 27 (64.3) | 21 (50.0) | 21 (50.0) | 32 (76.2) | 10 (23.8) | 24 (57.1) | 18 (42.9) | 38 (90.5) | 4 (9.5) |
5 or more/week | 5 (35.7) | 9 (64.3) | 8 (57.1) | 6 (42.9) | 12 (85.7) | 2 (14.3) | 6 (42.9) | 8 (57.1) | 12 (85.7) | 2 (14.3) |
X2 (p-value) | 0.377 (p = 0.828) | 3.413 (p = 0.182) | 1.622 (p = 0.444) | 5.636 (p = 0.06) | 0.659 (p = 0.719) | |||||
Cinnamon drink (portion) | ||||||||||
No intake | 200 (42.2) | 274 (57.8) | 310 (65.4) | 164 (34.6) | 348 (73.4) | 126 (26.6) | 328 (69.2) | 146 (30.8) | 412 (86.9) | 62 (13.1) |
1–4/week | 32 (32.30) | 67 (67.7) | 54 (54.5) | 45 (45.5) | 70 (70.7) | 29 (29.3) | 62 (62.6) | 37 (37.4) | 85 (85.9) | 14 (14.1) |
5 or more/week | 8 (23.5) | 26 (76.5) | 17 (50.0) | 17 (50.0) | 22 (64.7) | 12 (35.3) | 14 (41.2) | 20 (58.8) | 27 (79.4) | 7 (20.6) |
X2 (p-value) | 7.199 (p = 0.027) | 6.642 (p = 0.036) | 1.395 (p = 0.498) | 12.013 (p = 0.002) | 1.537 (p = 0.464) |
Covariate | Unadjusted | Adjusted for Age, BMI and WC |
---|---|---|
OR (95% CI) P | OR (95% CI) P | |
Fresh vegetables intake | ||
p for trend | p = 0.007 | p = 0.024 |
No intake (reference) | ||
1–4/week | 2.683 (1.416, 5.085) p = 0.002 | 2.499 (1.285, 4.859) p = 0.007 |
5 or more/week | 2.489 (1.34, 4.624) p = 0.004 | 2.072 (1.089, 3.941) p = 0.026 |
Cinnamon drink intake | ||
p for trend | p = 0.027 | p > 0.15 |
No intake (reference) | ||
1–4/week | 1.395 (0.873, 2.228) p = 0.163 | |
5 or more/week | 2.613 (1.142, 5.978) p = 0.023 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Enani, S.; Bahijri, S.; Malibary, M.; Jambi, H.; Eldakhakhny, B.; Al-Ahmadi, J.; Al Raddadi, R.; Ajabnoor, G.; Boraie, A.; Tuomilehto, J. The Association between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia. Nutrients 2020, 12, 2441. https://doi.org/10.3390/nu12082441
Enani S, Bahijri S, Malibary M, Jambi H, Eldakhakhny B, Al-Ahmadi J, Al Raddadi R, Ajabnoor G, Boraie A, Tuomilehto J. The Association between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia. Nutrients. 2020; 12(8):2441. https://doi.org/10.3390/nu12082441
Chicago/Turabian StyleEnani, Sumia, Suhad Bahijri, Manal Malibary, Hanan Jambi, Basmah Eldakhakhny, Jawaher Al-Ahmadi, Rajaa Al Raddadi, Ghada Ajabnoor, Anwar Boraie, and Jaakko Tuomilehto. 2020. "The Association between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia" Nutrients 12, no. 8: 2441. https://doi.org/10.3390/nu12082441
APA StyleEnani, S., Bahijri, S., Malibary, M., Jambi, H., Eldakhakhny, B., Al-Ahmadi, J., Al Raddadi, R., Ajabnoor, G., Boraie, A., & Tuomilehto, J. (2020). The Association between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia. Nutrients, 12(8), 2441. https://doi.org/10.3390/nu12082441